Mackenzie Financial’s CRISPR Therapeutics CRSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q1
Sell
-24,300
Closed -$1.84M 1429
2021
Q4
$1.84M Buy
+24,300
New +$1.84M ﹤0.01% 781